...
mdwd-img

Mediwound Ltd, Common Stock

MDWD

NMQ

$17.1

-$0.05

(-0.29%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$184.83M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
53.65K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.84
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$10.06 L
$24 H
$17.1

About Mediwound Ltd, Common Stock

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameMDWDSectorS&P500
1-Week Return-5.37%-2.82%0.15%
1-Month Return1.12%-4.22%1.78%
3-Month Return-2.9%-9.52%8.7%
6-Month Return6.34%-3.45%12.24%
1-Year Return67.48%5.62%30.9%
3-Year Return5.75%3.8%30.19%
5-Year Return-18.57%39.68%91.72%
10-Year Return-63.76%105.02%203.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue31.79M21.76M23.76M26.50M18.69M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.46,"profit":true},{"date":"2021-12-31","value":74.75,"profit":true},{"date":"2022-12-31","value":83.35,"profit":true},{"date":"2023-12-31","value":58.78,"profit":true}]
Cost of Revenue11.85M14.22M14.99M13.33M15.11M[{"date":"2019-12-31","value":78.43,"profit":true},{"date":"2020-12-31","value":94.11,"profit":true},{"date":"2021-12-31","value":99.23,"profit":true},{"date":"2022-12-31","value":88.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit19.94M7.54M8.77M13.16M3.58M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":37.84,"profit":true},{"date":"2021-12-31","value":43.99,"profit":true},{"date":"2022-12-31","value":66.02,"profit":true},{"date":"2023-12-31","value":17.94,"profit":true}]
Gross Margin62.73%34.67%36.91%49.69%19.15%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":55.27,"profit":true},{"date":"2021-12-31","value":58.84,"profit":true},{"date":"2022-12-31","value":79.21,"profit":true},{"date":"2023-12-31","value":30.53,"profit":true}]
Operating Expenses15.45M16.39M19.99M21.51M18.87M[{"date":"2019-12-31","value":71.81,"profit":true},{"date":"2020-12-31","value":76.17,"profit":true},{"date":"2021-12-31","value":92.94,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.72,"profit":true}]
Operating Income4.49M(8.84M)(11.22M)(8.35M)(15.29M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-196.75,"profit":false},{"date":"2021-12-31","value":-249.74,"profit":false},{"date":"2022-12-31","value":-185.73,"profit":false},{"date":"2023-12-31","value":-340.31,"profit":false}]
Total Non-Operating Income/Expense(4.98M)(985.00K)(3.38M)(13.43M)14.65M[{"date":"2019-12-31","value":-33.97,"profit":false},{"date":"2020-12-31","value":-6.72,"profit":false},{"date":"2021-12-31","value":-23.11,"profit":false},{"date":"2022-12-31","value":-91.7,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income2.07M(9.28M)(13.52M)(19.52M)(6.53M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-448.98,"profit":false},{"date":"2021-12-31","value":-654.6,"profit":false},{"date":"2022-12-31","value":-944.87,"profit":false},{"date":"2023-12-31","value":-316.12,"profit":false}]
Income Taxes(1.65M)325.00K27.00K78.00K185.00K[{"date":"2019-12-31","value":-508.31,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":8.31,"profit":true},{"date":"2022-12-31","value":24,"profit":true},{"date":"2023-12-31","value":56.92,"profit":true}]
Income After Taxes3.72M(9.60M)(13.55M)(19.60M)(6.72M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-258.23,"profit":false},{"date":"2021-12-31","value":-364.47,"profit":false},{"date":"2022-12-31","value":-527.14,"profit":false},{"date":"2023-12-31","value":-180.63,"profit":false}]
Income From Continuous Operations2.07M(9.28M)(13.55M)(19.60M)(12.43M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-448.98,"profit":false},{"date":"2021-12-31","value":-655.91,"profit":false},{"date":"2022-12-31","value":-948.64,"profit":false},{"date":"2023-12-31","value":-601.65,"profit":false}]
Income From Discontinued Operations2.89M80.00K---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":2.77,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income3.72M(9.60M)(13.55M)(19.60M)(6.72M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-258.23,"profit":false},{"date":"2021-12-31","value":-364.47,"profit":false},{"date":"2022-12-31","value":-527.14,"profit":false},{"date":"2023-12-31","value":-180.63,"profit":false}]
EPS (Diluted)1.26(2.31)(3.43)(3.77)(0.77)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-183.33,"profit":false},{"date":"2021-12-31","value":-272.22,"profit":false},{"date":"2022-12-31","value":-299.21,"profit":false},{"date":"2023-12-31","value":-61.11,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MDWD
Cash Ratio 1.78
Current Ratio 2.11
Quick Ratio 1.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MDWD
ROA (LTM) -15.77%
ROE (LTM) -75.66%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MDWD
Debt Ratio Lower is generally better. Negative is bad. 0.54
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.46

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MDWD
Trailing PE NM
Forward PE NM
P/S (TTM) 9.19
P/B 5.41
Price/FCF NM
EV/R 7.40
EV/Ebitda NM
PEG NM

FAQs

What is Mediwound Ltd share price today?

Mediwound Ltd (MDWD) share price today is $17.1

Can Indians buy Mediwound Ltd shares?

Yes, Indians can buy shares of Mediwound Ltd (MDWD) on Vested. To buy Mediwound Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MDWD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Mediwound Ltd be purchased?

Yes, you can purchase fractional shares of Mediwound Ltd (MDWD) via the Vested app. You can start investing in Mediwound Ltd (MDWD) with a minimum investment of $1.

How to invest in Mediwound Ltd shares from India?

You can invest in shares of Mediwound Ltd (MDWD) via Vested in three simple steps:

  • Click on Sign Up or Invest in MDWD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Mediwound Ltd shares
What is Mediwound Ltd 52-week high and low stock price?

The 52-week high price of Mediwound Ltd (MDWD) is $24. The 52-week low price of Mediwound Ltd (MDWD) is $10.06.

What is Mediwound Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Mediwound Ltd (MDWD) is

What is Mediwound Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Mediwound Ltd (MDWD) is 5.41

What is Mediwound Ltd dividend yield?

The dividend yield of Mediwound Ltd (MDWD) is 0.00%

What is the Market Cap of Mediwound Ltd?

The market capitalization of Mediwound Ltd (MDWD) is $184.83M

What is Mediwound Ltd’s stock symbol?

The stock symbol (or ticker) of Mediwound Ltd is MDWD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top